Form 4: Guardant Health Chief Medical Officer Reports Stock Transactions

Craig Eagle, Chief Medical Officer of Guardant Health, reported the acquisition of 1,402 shares and the disposal of 711 shares to cover tax obligations related to vesting restricted stock units.

Summary

• Craig Eagle, the Chief Medical Officer of Guardant Health, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On December 15, 2024, Mr. Eagle acquired 1,402 shares of common stock through the vesting of restricted stock units.
• Simultaneously, 711 shares were disposed of to cover tax withholding obligations associated with the vesting event.
• The price of the disposed shares was $34.76 per share.
• Following these transactions, Mr. Eagle directly owns 23,962 shares of Guardant Health common stock and 8,411 restricted stock units.

Sentiment

Score: 7

Explanation: The document reflects routine transactions related to executive compensation. There is no indication of any negative or positive sentiment beyond the normal course of business.

Positives

• The vesting of restricted stock units indicates a continued alignment of the executive's interests with the company's performance.
• The acquisition of shares through vesting increases the executive's stake in the company.

Negatives

• The disposal of shares, while for tax purposes, slightly reduces the executive's direct shareholding.

Risks

• The sale of shares to cover tax obligations could be perceived negatively by some investors, although it is a common practice.
• Fluctuations in the stock price could impact the value of the executive's holdings and future vesting events.

Future Outlook

The remaining 67% of the restricted stock units will vest in equal quarterly installments over the next two years.

Industry Context

This is a routine filing for a company with equity-based compensation, and the transactions are typical for executives receiving stock-based awards.

Comparison to Industry Standards

• Stock transactions by executives are common across the biotech and healthcare industries, particularly in companies that use equity-based compensation.
• Similar transactions are regularly reported by executives at companies like Exact Sciences (EXAS) and Illumina (ILMN), which also utilize stock options and restricted stock units as part of their compensation packages.
• The tax withholding practices are standard and consistent with industry norms for equity compensation.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are routine and related to executive compensation.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Next Steps

• The remaining restricted stock units will continue to vest quarterly over the next two years.
• Future Form 4 filings will likely be made as additional vesting events occur.

Key Dates

Keywords

Guardant Health, Craig Eagle, Form 4, stock transaction, restricted stock units, insider trading, beneficial ownership, tax withholding